Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen
- PMID: 12499269
Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen
Abstract
In photodynamic therapy (PDT), treatment efficacy may be reduced by the presence of pre-existing tumor hypoxia or by oxygen depletion during the therapy. Tumor oxygenation during PDT has been measured with needle electrodes, but the intratumoral distribution of this oxygen is not known. In the present study, the spatial distribution of hypoxia during PDT was quantified using the hypoxia-labeling marker EF3. Mice bearing radiation-induced fibrosarcoma tumors were treated with Photofrin-mediated PDT to a total dose of 135 J/cm(2), delivered at a fluence rate of either 75 mW/cm(2) or 38 mW/cm(2). PDT-created hypoxia at each fluence rate was labeled by exposing tumors to EF3 (52 mg/kg) during the period of illumination. Cryosectioning, immunohistochemistry, and fluorescence microscopy were carried out to quantify EF3 binding as a function of distance to the nearest perfused blood vessels in sections cut from within the superficial (light-adjacent) 600 micro m or the deep (light-distant) 600 micro m of tumors (5-6 mm in diameter, approximately 3 mm in depth). In both superficial and deep sections, PDT at 75 mW/cm(2) resulted in the development of significant gradients in tumor hypoxia as a function of distance to a perfused blood vessel. Furthermore, significant hypoxia was detected even in vascular-adjacent tissue. These effects were associated with a significant decrease in the percentage of perfused vessels and a significant increase in the median distance of a cell to the nearest perfused blood vessel. In contrast, during PDT at 38 mW/cm(2), sections from deep tumor levels demonstrated only insignificant increases in the rise in hypoxia as a function of distance to a perfused vessel and in the level of hypoxia in vascular-adjacent tissue. No effects on tumor perfusion were detected during PDT at 38 mW/cm(2). Overall, these results demonstrate that spatially dependent depletion of oxygen can occur during PDT as a function of the fluence rate and that PDT can create significant hypoxia in even tissue adjacent to perfused blood vessels.
Similar articles
-
Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].Cancer Res. 2000 May 15;60(10):2636-42. Cancer Res. 2000. PMID: 10825135
-
Fluence rate as a modulator of PDT mechanisms.Lasers Surg Med. 2006 Jun;38(5):489-93. doi: 10.1002/lsm.20327. Lasers Surg Med. 2006. PMID: 16615136 Review.
-
Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.Cancer Res. 2004 Oct 15;64(20):7553-61. doi: 10.1158/0008-5472.CAN-03-3632. Cancer Res. 2004. PMID: 15492282
-
The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.Photochem Photobiol. 1998 Apr;67(4):462-6. Photochem Photobiol. 1998. PMID: 9559590
-
Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.Radiat Res. 1997 Oct;148(4):386-94. Radiat Res. 1997. PMID: 9339955 Review.
Cited by
-
Photodynamic therapy and associated targeting methods for treatment of brain cancer.Front Pharmacol. 2023 Sep 28;14:1250699. doi: 10.3389/fphar.2023.1250699. eCollection 2023. Front Pharmacol. 2023. PMID: 37841921 Free PMC article. Review.
-
Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.Theranostics. 2015 Jan 1;5(3):289-301. doi: 10.7150/thno.10155. eCollection 2015. Theranostics. 2015. PMID: 25553116 Free PMC article.
-
A pilot randomized clinical study of the additive treatment effect of photodynamic therapy in breast cancer patients with chest wall recurrence.J Breast Cancer. 2014 Jun;17(2):161-6. doi: 10.4048/jbc.2014.17.2.161. Epub 2014 Jun 27. J Breast Cancer. 2014. PMID: 25013438 Free PMC article.
-
Increasing damage to tumor blood vessels during motexafin lutetium-PDT through use of low fluence rate.Radiat Res. 2010 Sep;174(3):331-40. doi: 10.1667/RR2075.1. Radiat Res. 2010. PMID: 20726728 Free PMC article.
-
Sulphur-doped carbon dots as a highly efficient nano-photodynamic agent against oral squamous cell carcinoma.Cell Prolif. 2020 Apr;53(4):e12786. doi: 10.1111/cpr.12786. Cell Prolif. 2020. PMID: 32301195 Free PMC article.